Dennis E. Slater
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Prostate Cancer Treatment and Research 3
- Lung Cancer Diagnosis and Treatment 2
-
- Venous Thromboembolism Diagnosis and Management 3
- Co-authors
- David J. Straus (1 shared paper)R Mertelsmann (1 shared paper)Sanford Jay Kempin (1 shared paper)Z A Arlin (1 shared paper)Toby Gee (1 shared paper)Benjamín Koziner (1 shared paper)Peter K. Schauer (1 shared paper)Susan McKenzie (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Radiology (3 papers)Blood (1 paper)Thrombosis and Haemostasis (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesSouth KoreaIsrael
In The Last Decade
Dennis E. Slater
14 papers receiving 910 citations
Dennis E. Slater's Hit Papers
Peers
Comparison fields: 5 of 53
- Internal Medicine 105
- Oncology 250
- Surgery 358
- Pathology and Forensic Medicine 85
- Pulmonary and Respiratory Medicine 132
Countries citing papers authored by Dennis E. Slater
This map shows the geographic impact of Dennis E. Slater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis E. Slater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis E. Slater more than expected).
Fields of papers citing papers by Dennis E. Slater
This network shows the impact of papers produced by Dennis E. Slater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis E. Slater. The network helps show where Dennis E. Slater may publish in the future.
Co-authors
The 25 scholars most cited alongside Dennis E. Slater, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2021 | 490 |
| 2 | 1986 | 96 | |
| 3 | 2022 | 75 | |
| 4 | 2023 | 72 | |
| 5 | 2019 | 65 | |
| 6 | 2019 | 51 | |
| 7 | 2023 | 46 | |
| 8 | 2021 | 14 | |
| 9 | 1997 | 13 | |
| 10 | 2024 | 9 | |
| 11 | 2024 | 4 | |
| 12 | 2025 | 4 | |
| 13 | 2010 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2021 | 0 | |
| 16 | 2023 | 0 |
About Dennis E. Slater
Dennis E. Slater is a scholar working on Pulmonary and Respiratory Medicine, Internal Medicine, Oncology, Rheumatology and Pathology and Forensic Medicine, having authored 16 papers that have together received 941 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Prostate Cancer Treatment and Research (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Bladder and Urothelial Cancer Treatments (1 paper). The work is most often cited by research in Internal Medicine (105 citations), Oncology (250 citations), Surgery (358 citations), Pathology and Forensic Medicine (85 citations) and Pulmonary and Respiratory Medicine (132 citations). Dennis E. Slater has collaborated with scholars based in United States, South Korea and Israel. Frequent co-authors include David J. Straus, R Mertelsmann, Sanford Jay Kempin, Z A Arlin, Toby Gee, Benjamín Koziner, Peter K. Schauer, Susan McKenzie, Antonio Carlos Buzaid and Anthony James Comerota. Their work appears in journals such as Annals of Oncology, Radiology, Blood, Thrombosis and Haemostasis and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.